ArticleScience translational medicine2017
CD99 is a therapeutic target on disease stem cells in myeloid malignancies.
Stephen S Chung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
99 papers cite itlatest 60 shown
this papertrialcites it